Regina I. Jakacki

Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial

Jason Fangusaro, Arzu Onar‐Thomas, Tina Young Poussaint et al. · The Lancet Oncology · 2019 · 502 citations · Full text

Medicine, Oncology, Pediatrics +16

Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood.

Roger J. Packer, Beverly J. Lange, J Ater et al. · Journal of Clinical Oncology · 1993 · 357 citations

Medicine, Oncology, Pediatrics +14

A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study

Anuradha Banerjee, Regina I. Jakacki, Arzu Onar‐Thomas et al. · Neuro-Oncology · 2017 · 320 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase II Study of Weekly Vinblastine in Recurrent or Refractory Pediatric Low-Grade Glioma

Éric Bouffet, Regina I. Jakacki, Stewart Goldman et al. · Journal of Clinical Oncology · 2012 · 228 citations · Full text

Medicine, Oncology, Pharmacology +17

Outcome of Children With Metastatic Medulloblastoma Treated With Carboplatin During Craniospinal Radiotherapy: A Children's Oncology Group Phase I/II Study

Regina I. Jakacki, Peter C. Burger, Tianni Zhou et al. · Journal of Clinical Oncology · 2012 · 219 citations · Full text

Medicine, Oncology, Radiation Oncology +16